Rupa Health is a technology company.
Rupa Health has raised $26.0M across 2 funding rounds.
Rupa Health has raised $26.0M in total across 2 funding rounds.
Rupa Health is a technology platform that streamlines ordering, tracking, and results management for over 3,000 specialty lab tests from 30+ labs, enabling healthcare practitioners to deliver root cause medicine—personalized, data-driven care addressing underlying health issues like genomics, microbiome, nutrition, and lifestyle factors rather than symptoms.[1][2][3][4][6] It serves licensed providers (doctors, chiropractors, dietitians) in solo practices, clinics, hospitals, and integrative departments across all 50 U.S. states, solving the fragmentation of specialty diagnostics that previously took practitioners 15+ hours weekly in admin work, now reduced to minutes via a single portal with transparent pricing, SMS orders, and patient-friendly tools.[1][2][3][6] The company supports half a million patients and practitioners monthly, with strong growth including quadrupling revenue in 2021 and serving tens of thousands of clinics by 2024, bolstered by educational resources like Rupa University, Magazine, and Podcast.[3][4]
Rupa Health was founded in 2020 by CEO Tara Viswanathan, co-founders Rosa Hamalainen, and Ben Easton, inspired by Tara's personal experience navigating her mother's chronic illness through integrative diagnostics like genomics and microbiome testing, which restored her health in weeks via personalized protocols.[1][5] Frustrated by fragmented lab access and siloed medicine, they launched a prototype in January 2020 to two Bay Area doctors, expanding within three months to nearly every state and major systems like UC Irvine and Sutter Health's Palo Alto Medical Foundation.[2] Early funding included $5.8M from First Round Capital, Floodgate, SV Angel, and others, followed by a $20M Series A led by Bessemer Venture Partners, fueling growth to thousands of providers and 3,000+ tests.[1][2][3]
Rupa Health rides the root cause medicine revolution, fueled by consumer demand (88% want personalized care per CVS survey), mainstream adoption (40% of hospitals adding integrative centers, top med schools like Johns Hopkins training providers), and market shifts like high-deductible plans, at-home testing, and telemedicine.[1][2] Timing aligns with post-2020 health awareness surges, chronic disease burdens (leading noncommunicable killer), and frustration with symptom-focused pharma models, positioning Rupa to mainstream "fringe" diagnostics for holistic care linking mental-physical health, gut biome, and nutrition.[1][3][5][7] It influences the ecosystem by powering infrastructure for functional/precision medicine, supporting half a million users monthly, and accelerating provider adoption amid rising personalized health tech.[3][4]
In October 2024, Fullscript acquired Rupa, integrating its lab platform with supplement dispensing for end-to-end diagnostics-to-treatment workflows, amplifying impact in whole-person care.[4]
Post-acquisition by Fullscript, Rupa will likely deepen synergies in personalized care stacks, expanding from diagnostics to integrated supplementation and AI-driven protocols for chronic conditions.[4][7] Trends like AI personalization, at-home biotech, and evidence-based integrative medicine will propel growth, as high-deductible plans and consumer empowerment drive demand for root cause approaches amid chronic illness epidemics.[1][5] Its influence may evolve from lab aggregator to core enabler of data-driven, holistic healthcare ecosystems, potentially globalizing "root cause medicine for every person" while scaling education to millions of providers.[3][5] This builds on its mission to transform fragmented care into accessible, proactive health.
Rupa Health has raised $26.0M in total across 2 funding rounds.
Rupa Health's investors include ACME Capital, Amazon Alexa Fund, Awesome Ventures, Adeyemi Ajao, Bessemer Venture Partners, Convoz, Cowboy Ventures, Craft Ventures, Draper Associates, First Round Capital, Floodgate, foobar.vc.
Rupa Health has raised $26.0M across 2 funding rounds. Most recently, it raised $20.0M Series A in February 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 1, 2022 | $20.0M Series A | ACME Capital, Amazon Alexa Fund, Awesome Ventures, Adeyemi Ajao, Bessemer Venture Partners, Convoz, Cowboy Ventures, Craft Ventures, Draper Associates, First Round Capital, Floodgate, foobar.vc, Generative Ventures, Giant Ventures, Jetstream, Kapor Capital, LGF, Lightbank, Liquid 2 Ventures, Long Journey Ventures, Maveron, Motier Ventures, Ravelin Capital, Silicon Valley Connect, Spark Capital, Stash Ventures, The Fintech Fund, TQ Ventures, Viola Ventures, Alexis Bonillo, Andrew Robb, Brad Lewthwaite, Charlie Songhurst, Colin Carrier, Gloria Baeuerlein, Joao Otavio Oliverio, Justin Mateen, Justin Timberlake, Kevin Colas, Kevin Weil, Koen Bok, Leonardo DiCaprio, Manu Ginobilli, Nicholas Francis, Paul Veugen, Pedro Arnt, Richard Branson, Ron Pragides, Russell Smith, Scott Belsky, Shervin Pishevar, Steven Sinofsky, Stewart Butterfield, Thomas Vu, Tom Blomfield, Tuomas Artman, William Miller | |
| Aug 1, 2021 | $6.0M Seed | ACME Capital, Amazon Alexa Fund, Convoz, Cowboy Ventures, Craft Ventures, Draper Associates, First Round Capital, Floodgate, Generative Ventures, Kapor Capital, LGF, Lightbank, Long Journey Ventures, Maveron, Ravelin Capital, Silicon Valley Connect, Spark Capital, Stash Ventures, The Fintech Fund, TQ Ventures, Viola Ventures, Brad Lewthwaite, Colin Carrier, Gloria Baeuerlein, Joao Otavio Oliverio, Justin Mateen, Justin Timberlake, Kevin Colas, Kevin Weil, Koen Bok, Paul Veugen, Ron Pragides, Russell Smith, Scott Belsky, Shervin Pishevar, Steven Sinofsky, Stewart Butterfield, Tuomas Artman, William Miller |